DEXMEDETOMIDINE EVER PHARMA 100mcg/ml Concentrate for solution for infusion in UAE 2023

 Introduction to DEXMEDETOMIDINE EVER PHARMA 100mcg/ml

DEXMEDETOMIDINE EVER PHARMA 100mcg/ml is a medication used for sedation in adult intensive care unit (ICU) patients. The active ingredient in DEXMEDETOMIDINE EVER PHARMA 100mcg/ml is dexmedetomidine, a selective alpha-2 adrenergic receptor agonist that produces sedative and analgesic effects.

How does DEXMEDETOMIDINE EVER PHARMA 100mcg/ml work?

DEXMEDETOMIDINE EVER PHARMA 100mcg/ml works by selectively activating alpha-2 adrenergic receptors in the brain, resulting in sedation and analgesia. It has minimal respiratory depression and does not cause significant changes in heart rate or blood pressure, making it a preferred choice for sedation in ICU patients.

Dosage and Administration of DEXMEDETOMIDINE EVER PHARMA 100mcg/ml

DEXMEDETOMIDINE EVER PHARMA 100mcg/ml is administered through an IV infusion and should only be administered by a healthcare professional trained in its use. The recommended initial dose is 0.2-0.7 mcg/kg/hour, and the dose can be titrated up or down to achieve the desired level of sedation. It is important to monitor the patient s vital signs and level of consciousness while on DEXMEDETOMIDINE EVER PHARMA 100mcg/ml.

Precautions and Side Effects of DEXMEDETOMIDINE EVER PHARMA 100mcg/ml

Like any medication, DEXMEDETOMIDINE EVER PHARMA 100mcg/ml may cause side effects. Common side effects include hypotension, bradycardia, and dry mouth. However, these side effects can be managed with appropriate monitoring and medication adjustments.

DEXMEDETOMIDINE EVER PHARMA 100mcg/ml should be used with caution in patients with pre-existing cardiovascular disease or those who are hemodynamically unstable. It should also be used with caution in patients with severe hepatic impairment, as the drug is metabolized in the liver.

DEXMEDETOMIDINE EVER PHARMA 100mcg/ml Concentrate for solution for infusion Alternatives